Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B

Related articles

1. TDF and its analogs have not survival advantage over entecavir for patients with Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure

   This article has 11 authors:

   1. Xinyi Xu
   2. Huilan Tu
   3. Xianbin Xu
   4. Xia Yu
   5. Haoda Weng
   6. Yue Yu
   7. Xiuding Zhang
   8. Ruoqi Zhou
   9. Wenfeng Zhu
   10. Shi Yu
   11. Jifang Sheng

2. Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study

   This article has 20 authors:

   1. Hideto Kawaratani
   2. Tadashi Namisaki
   3. Yasuteru Kondo
   4. Ryoji Tatsumi
   5. Naoto Kawabe
   6. Norikazu Tanabe
   7. Akira Sakamaki
   8. Kyoko Hoshikawa
   9. Yoshihito Uchida
   10. Kei Endo
   11. Takumi Kawaguchi
   12. Tsunekazu Oikawa
   13. Yoji Ishizu
   14. Shuhei Hige
   15. Taro Takami
   16. Shuji Terai
   17. Yoshiyuki Ueno
   18. Satoshi Mochida
   19. Kazuhiko Koike
   20. Hitoshi Yoshiji

3. Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B

   This article has 8 authors:

   1. Qianqian Ma
   2. Junzhao Ye
   3. Ling Luo
   4. Yanhong Sun
   5. Wei Wang
   6. Shiting Feng
   7. Bing Liao
   8. Bihui Zhong